European Lifecycle Management
Scientific knowledge to strategize viable and efficient drug and device development pathways to achieve successful outcomes

The World's Leading Regulatory Partner in Europe
Unlock the full potential of your product. Post-Approval, ProPharma’s team of expert regulatory consultants ensures compliance with regulatory requirements across Europe and maximizes your product’s impact. At ProPharma, we recognize that every organization has unique regulatory needs. Whether you’re a global corporation or a local player, our flexible approach ensures that you receive the right level of support. ProPharma is more than a service provider; we’re your strategic partner in regulatory excellence.
Explore Our European Regulatory Lifecycle Management Services
We share your commitment to keeping innovative products on the market and in the hands of patients who need them most.
Regulatory Product Launch
Optimizing the value of a medicine from a regulatory perspective is a multifaceted endeavor, which necessitates meticulous planning. Each country or region has unique regulatory requirements, healthcare systems, and market dynamics. In this context, a robust post-approval launch strategy plays a pivotal role in ensuring a successful post-approval product launch. Local regulatory launch plans are essential for navigating country-specific intricacies, ensuring compliance, and optimizing market access.
Our Regulatory Product Launch Consulting Support Includes:
- Project management; multi-country
- Product launch checklists
- Review of artwork for printing
- Registration in local regulatory databases
- Publication of product information in local catalogue texts
- Registration with local serialization verification organizations
- Advice on specific local country regulatory requirements
European Regulatory Lifecycle Management
After your initial application has received marketing approval from the regulators, you need to remain compliant with all regulatory requirements needed to keep your product on the market. A strategic approach to lifecycle management is necessary to maximize the potential of your product.
ProPharma serves as a true extension of your team, helping you with every aspect of regulatory lifecycle management activities. Our team of regulatory affairs consultants is made up of scientists who possess a deep understanding of the intricacies of regulatory lifecycle management across all phases of the product lifecycle.
We have extensive knowledge and experience in project management as well as submission and procedural management and can partner with you at any point in the process to provide strategic input and end-to-end planning of submission activities, e.g. analyze and prepare documentation, compile the submission, publish, and submit the application and correspond with relevant health authorities.
Our European Regulatory Lifecycle Management Consulting Services Include:
- GAP analysis and submission strategy
- Dossier compilation
- Regulatory advice, including pre-submission meetings
- All types of regulatory submission, e.g. variations (e.g., labelling, referrals), line extensions, renewals
- Publishing (eCTD)
- MAH-transfers
- CMC support, including strategic advice, Module 3 updates, and technology transfers
- Health Authority liaison services (communication)
- Support for post-authorization commitments
- Management of catalogue texts
- Management of local regulatory databases
- Product information (PI) updates/translations
- Artwork reviews
- Readability testing
Regulatory Project Management
In the dynamic landscape of pharmaceuticals, regulatory compliance is paramount. From drug development to market approval and commercialization, every step requires meticulous planning, coordination, and adherence to global standards. This is where Regulatory Project Management steps in as a critical function.
The Role of a Regulatory Project Manager in the Pharmaceutical Product Lifecycle

Regulatory pathways vary across countries and regions. Regulatory project managers must be dynamic individuals, often serving as the team leader, acting as the “central hub” connecting the internal teams and external stakeholders as they work to eliminate potential hurdles across functional areas. A good regulatory project manager is a detailed planner by nature, ensuring seamless continuity throughout the product’s lifecycle.
At ProPharma, our team of regulatory project management consultants are well versed in the complexities of the global regulatory landscape, with extensive experience working with our clients to successfully navigate the maze of global regulatory requirements.
Our Regulatory Project Management Consulting Support Includes:
- Expert team of Regulatory Project Management consultants with extensive experience combining scientific, regulatory, and business knowledge to ensure products that are developed, manufactured, or distributed meet regulators’ expectations at regional, national, and local levels
- RPM coordination of all European Regulatory activities (Regulatory submission strategy, multi-country Product Launch, Product Lifecycle Management, Regulatory Intelligence, and Promotional Materials Review)
- End-to-end planning, coordination, and execution of regulatory procedures and submissions
- Delivery through proactive and open communication, effective project planning, stakeholder management, leading cross-functional teams, communication planning, risk mitigation, and issues resolution
Regulatory Intelligence
In the ever-changing regulatory landscape, staying informed of applicable regulatory requirements is crucial. Regulatory Intelligence involves systematically gathering and analyzing publicly available information related to regulations. Monitoring regulatory changes demands seasoned expertise and our team brings years of experience, providing you with actionable insights that empower your compliance efforts.
Our Regulatory Intelligence Consulting Services Include:
- Global and local Regulatory Intelligence support
- Strategic advice on national legislation and specific requirements
- Monitoring evolving information and responding to changes in the regulatory landscape
- Identifying, integrating, and analyzing regulatory information
- Reporting according to customer requirements
Review of Promotional Materials
In the life sciences industry, reviewing promotional materials is not just a formality; it’s a critical step in ensuring compliance, patient safety, and brand reputation. Promotional materials must adhere to strict local regulations and deviations can lead to penalties, product recalls, or legal consequences. Rigorous review ensures that claims are evidence-based and do not misrepresent the product’s benefits or risks. Promotional materials directly impact how healthcare professionals and patients perceive a product. A well-reviewed campaign enhances trust, while errors can tarnish the brand's image.
Our European Promotional Review Consulting Services Include:
- Regulatory review of promotional materials in accordance with the respective ethical codes in the local country
- Creation and update of Abbreviated Product Information (API) texts
- Support in setting up a routine for local review of promotional materials in the local country
- Advice on general questions regarding the local ethical codes
Outsourced Regulatory Affairs Functions
In today’s dynamic business landscape, organizations face increasing regulatory complexities. Navigating global and local regulations demands expertise, resources, and strategic planning. We recognize that each client is unique and adapt our service offering according to our clients’ needs. Outsourcing regulatory functions can be a strategic move to optimize efficiency, enhance compliance, and focus on core business objectives. Whether you’re a multinational corporation or a local player, understanding the benefits and considerations of outsourcing your regulatory affairs obligations is crucial. At ProPharma, we don’t just manage projects; we drive them forward. With our unwavering commitment to oversight, strategic thinking, and client engagement, we’re your trusted partner in achieving regulatory success.
Outsourcing all or part(s) of your regulatory affairs department to ProPharma’s team of Regulatory Sciences experts provides access to a pool of seasoned professionals.
- Our regulatory consultants understand the intricacies of diverse regulatory frameworks, ensuring accurate submissions, compliance, and timely approvals. Our consultants bring a wealth of experience and up-to-date knowledge of global regulatory standards, ensuring your projects meet all necessary requirements. Our team collaborates with yours to fine-tune strategies, optimize resource allocation, and align with your business goals.
- We work in close collaboration with our clients to identify business goals, set and refine strategies, address potential challenges, and celebrate milestones.
- We understand that business needs may change over time and our agility ensures that we pivot when needed. Maintaining an in-house regulatory team can be resource intensive. Outsourcing allows you to allocate your resources more efficiently, reducing overhead costs while maintaining quality. Our team can be scaled up or down based on project needs without the long-term commitment of full-time hires.
- Navigating international markets requires knowledge of local regulations. ProPharma’s global reach ensures compliance across borders, enabling market expansion without compromising quality.
Whether you opt to outsource your all or just a portion of your Regulatory Affairs function or prefer an integrated approach where our consultants become part of your team, ProPharma is here to support you. ProPharma provides tailored and seamless solutions according to our clients’ needs.
Are you ready to achieve regulatory success?
ProPharma is the leading regulatory consultancy in the world. Contact us today to lean how we can help you successfully achieve your global regulatory goals.
Regulatory Science Experts
-
Lucy Radley
Senior Vice President, European Regulatory Development
-
Elizabeth Soames
Group Head, Nonclinical Regulatory Sciences
-
Paula van Hennik
Group Head Medical and Regulatory Sciences
-
Rhydian Howells
CMC Expert
Biologics and ATMPs -
Bertine Vorstenbosh
CMC Expert
Small Molecules -
Frank de Vries
Vice President, Strategy, Regulatory Sciences – Development
View Bio
-
Jens van Wijngaarden
Senior Director, Regulatory Sciences
-
Louisa Vangsted-Rees
CTA Submissions Expert
-
Sarah Bell
Paediatric Investigation Plan Expert
Lucy Radley
Elizabeth Soames
Paula van Hennik
Rhydian Howells
Bertine Vorstenbosh
Frank de Vries
Frank has over 30 years of experience in industry in a broad Regulatory Scientific field across all product types and multiple therapeutic areas including (pediatric) rare diseases and leads a team of subject matter experts in Regulatory Sciences to advise, support or lead overall regulatory strategy development and execution.
Frank’s broad and varied experience within the drug development industry includes significant interaction with the European Medicines Agency (EMA) and majority of national regulatory agencies across Europe, Middle East, CIS Region, Africa and to a certain extent LATAM, APAC, Canada, Australia, US. Regulatory interactions include but are not limited to scientific advice/protocol assistance, orphan applications and maintenance, pediatric investigation plans, early interactions, pre-submission meetings with EMA and/or Rapp/Co-Rapp and full marketing authorisation application pre-submission and full procedural support.
Frank has led various due diligence activities for product or portfolio acquisition and supported various Mergers & Acquisitions and served as international expert witness in arbitration court cases. Aside from Regulatory Scientific experience, Frank also held positions in Business Development, In/out-licensing, Commercial, Marketing & Sales, Quality and Pharmacovigilance.
Jens van Wijngaarden
Louisa Vangsted-Rees
Sarah Bell

Complex Needs Require Custom Solutions
ProPharma builds solutions at the intersection of innovation and flexibility. We’re here to offer a custom alternative that fits your unique needs. Standout solutions scaled to your size.
News & Insights

June 10, 2025
Navigating FDA's Q-Submission Process: A Strategic Advantage for Medical Device Developers
Learn how FDA’s Q-Submission process, especially Pre-Subs, offers a strategic advantage for medical device developers seeking regulatory clarity and approval.

June 6, 2025
From Discovery to Discontinuation: How Medical Information Supports Every Stage
Explore how MI services support every stage of pharmaceutical product development, from discovery to post-marketing, ensuring safety and compliance.

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

June 10, 2022
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

August 31, 2022
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
News & Insights